MLFMV.LS Farminveste jumps 15.89% to €3.50 on EURONEXT: Forecast upside

MLFMV.LS Farminveste jumps 15.89% to €3.50 on EURONEXT: Forecast upside

MLFMV.LS stock climbed 15.89% to €3.50 at market close on 19 Jan 2026 on EURONEXT, driven by a sharp volume spike to 2,120 shares versus an average of 118. The move left the intraday range locked at €3.50 (open and close), after a previous close of €3.02. Investors reacted to stronger-than-normal trading, recent positive company commentary about its healthcare operations in Portugal and a technical bounce off the 200-day average. We examine fundamentals, technicals, Meyka AI grade and forecasts to show where MLFMV.LS may head next.

Price action and drivers for MLFMV.LS stock

Today Farminveste, S.G.P.S., S.A. (MLFMV.LS) rose 15.89% to €3.50 on EURONEXT with 2,120 shares traded, a relative volume of 17.97. The stock opened at €3.50 and both day low and day high were €3.50, reflecting a concentrated surge of buy orders and limited liquidity. Year-to-date the share price is up 15.89% and one-year performance shows +201.72%, signalling strong recent momentum that traders cited on platforms and in short-term screens. For quick reference see the company site for corporate context source and model data on FinancialModelingPrep source.

Fundamentals and valuation of Farminveste (MLFMV.LS)

Farminveste reports a market cap of €69,999,426 and 19,999,836 shares outstanding. The company combines pharmacies, pharmaceutical distribution, hospitals and healthcare IT across Portugal. Key balance-sheet metrics show book value per share €13.92, price-to-book 0.3552, price-to-sales 0.08106, and enterprise value €254,254,075. Reported EPS in the quote is -1.18 with a listed PE of -2.97, while modelled trailing P/E in the key metrics reads 1.36, reflecting different period bases and accounting items. Investors should note return on equity 29.76% and debt-to-equity 1.09, which indicate strong ROE but elevated leverage versus peers.

Technicals and trading signals for MLFMV.LS stock

Technical indicators show oversold conditions and a strong directional move: RSI 23.53 (oversold), MACD histogram -0.14 with MACD -0.36, and ADX 41.55 signalling a strong trend. The price sits below the 50-day average (€3.98) and above the 200-day average (€3.06), a mixed signal that often precedes mean-reversion or continuation rallies. Bollinger Bands are Lower €2.41 / Middle €4.05 / Upper €5.69, implying room to mean-revert but also wide volatility; average true range (ATR) is €0.12, so traders should expect swings.

Meyka AI rates MLFMV.LS with a score out of 100 and forecast

Meyka AI rates MLFMV.LS with a score out of 100: the proprietary score is 65.17 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly €2.99, quarterly €3.99, and yearly €4.896416901839701. Compared with the current price €3.50, the yearly forecast implies an upside of 39.90%, while the quarterly €3.99 implies 14.00% upside. Forecasts are model-based projections and not guarantees; they should be used alongside fundamental and liquidity checks.

Sector context and key risks for MLFMV.LS

Farminveste operates in the Industrials sector with a healthcare focus; sector averages show higher liquidity and lower leverage. Farminveste’s current ratio 0.99 is below the sector average 2.76, raising short-term liquidity risk. Net debt to EBITDA is 6.07, and interest coverage is 0.85, which indicate refinancing and coverage risk if earnings weaken. Operational exposure across pharmacies, distribution and hospitals offers diversification, but the company’s leverage and low free-cash-flow yield 0.012 are main risk points for investors.

Price targets, trading strategy and liquidity notes

Meyka-aligned targets: conservative near-term €3.99 (quarterly forecast), base 12-month €4.90, and a bull three-year target €8.23. From €3.50, those imply +14.00%, +39.90%, and +135.00% respectively. Low average volume (118) means price moves can be sharp on limited orders; today’s volume spike to 2,120 drove the move. For traders, prioritise limit orders and small position sizing, and for longer-term investors, monitor leverage metrics and quarterly cash flow. See the Meyka stock page for live signals and alerts meyka stock page.

Final Thoughts

MLFMV.LS stock closed market on 19 Jan 2026 at €3.50, up 15.89%, on a pronounced liquidity spike. The price action reflects short-term buying interest and a technical bounce above the 200-day average, but fundamentals show a mixed picture: strong ROE 29.76% and low price-to-book 0.36 are offset by elevated leverage (debt-to-equity 1.09), tight cash conversion and a current ratio 0.99 below industrial peers. Meyka AI’s forecast model projects a 12‑month target of €4.896416901839701, implying ~39.90% upside versus today’s price; the quarterly model target €3.99 implies +14.00%. Forecasts are model-based projections and not guarantees. Short-term traders can capitalise on volatility but should respect low liquidity and set disciplined stops. Longer-term investors should watch upcoming cash flow, leverage reduction and operational updates from Farminveste, and reassess if quarterly results improve coverage metrics. Meyka AI provides the grade and model as an AI-powered market analysis platform to support due diligence, not as investment advice.

FAQs

What drove today’s rise in MLFMV.LS stock?

A concentrated buying surge lifted MLFMV.LS 15.89% to €3.50, with volume 2,120 versus average 118. The move reflects short-term demand, technical bounce and selective interest in healthcare exposure; low liquidity amplified the price change.

What price does Meyka AI forecast for MLFMV.LS?

Meyka AI’s forecast model projects a 12-month price of €4.896416901839701, implying ~39.90% upside from €3.50 today. These model outputs are projections and are not guarantees.

Is MLFMV.LS a buy after the jump?

The stock shows momentum but also liquidity and leverage risks. With a Meyka grade B (HOLD), consider small position sizes and wait for clearer cash-flow improvement or lower net-debt before committing larger capital.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *